Reaction
Ocular Toxicity reporting signals
As of the last recalculation, Ocular Toxicity appears in 1,044 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is ENCORAFENIB (PRR 60.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Encorafenib | 29 | 60.0 | 60.2 |
| Cefuroxime | 25 | 44.6 | 44.7 |
| Rifampin | 22 | 30.7 | 30.7 |
| Panitumumab | 23 | 29.9 | 30.0 |
| Rifampicin | 12 | 23.9 | 23.9 |
| Fam-Trastuzumab Deruxtecan-Nxki | 11 | 22.0 | 22.0 |
| Isoniazid | 17 | 21.2 | 21.3 |
| Dabrafenib | 21 | 20.3 | 20.3 |
| Trametinib | 24 | 20.2 | 20.3 |
| Pyrazinamide | 9 | 19.3 | 19.3 |
| Amikacin | 16 | 19.0 | 19.0 |
| Voriconazole Injection | 20 | 18.7 | 18.7 |
| Vemurafenib | 11 | 18.4 | 18.4 |
| Hydroxychloroquine | 59 | 16.6 | 16.7 |
| Pemetrexed | 17 | 16.1 | 16.1 |
| Hydroxychloroquine Sulfate | 62 | 14.4 | 14.4 |
| Vigabatrin | 10 | 13.8 | 13.8 |
| Fluorouracil | 50 | 13.5 | 13.5 |
| Bortezomib | 57 | 13.4 | 13.4 |
| Voriconazole | 20 | 13.4 | 13.4 |
| Fluorouracil Cream, 0.5% | 44 | 12.0 | 12.0 |
| Oxaliplatin | 42 | 11.7 | 11.7 |
| Daratumumab | 22 | 11.2 | 11.2 |
| Pemetrexed Disodium | 17 | 9.0 | 9.0 |
| Cetuximab | 14 | 9.0 | 9.0 |
| Aflibercept | 7 | 4.5 | 4.5 |